Geitzenauer W - Search Results

1

Comparison of 2.5 mg/kg and 5 mg/kg systemic bevacizumab in neovascular age-related macular degeneration: twenty-four week results of an uncontrolled, prospective cohort study.

Geitzenauer W, Michels S, Prager F, Rosenfeld PJ, Kornek G, Vormittag L, Schmidt-Erfurth U. Geitzenauer W, et al. Retina. 2008 Nov-Dec;28(10):1375-86. doi: 10.1097/IAE.0b013e3181863f96. Retina. 2008. PMID: 18784625 Clinical Trial.

2

Time course and morphology of vascular effects associated with photodynamic therapy.

Schmidt-Erfurth U, Niemeyer M, Geitzenauer W, Michels S. Schmidt-Erfurth U, et al. Among authors: geitzenauer w. Ophthalmology. 2005 Dec;112(12):2061-9. doi: 10.1016/j.ophtha.2005.09.007. Ophthalmology. 2005. PMID: 16325705

3

Influence of treatment parameters on selectivity of verteporfin therapy.

Michels S, Hansmann F, Geitzenauer W, Schmidt-Erfurth U. Michels S, et al. Among authors: geitzenauer w. Invest Ophthalmol Vis Sci. 2006 Jan;47(1):371-6. doi: 10.1167/iovs.05-0354. Invest Ophthalmol Vis Sci. 2006. PMID: 16384987

4

Retinal pigment epithelium tears following verteporfin therapy combined with intravitreal triamcinolone.

Michels S, Aue A, Simader C, Geitzenauer W, Sacu S, Schmidt-Erfurth U. Michels S, et al. Among authors: geitzenauer w. Am J Ophthalmol. 2006 Feb;141(2):396-398. doi: 10.1016/j.ajo.2005.08.046. Am J Ophthalmol. 2006. PMID: 16458709

5

Evaluation of anterior chamber inflammatory activity in eyes treated with intravitreal bevacizumab.

Kiss C, Michels S, Prager F, Weigert G, Geitzenauer W, Schmidt-Erfurth U. Kiss C, et al. Among authors: geitzenauer w. Retina. 2006 Oct;26(8):877-81. doi: 10.1097/01.iae.0000237080.10627.b7. Retina. 2006. PMID: 17031286

6

Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment.

Bolz M, Michels S, Geitzenauer W, Prager F, Schmidt-Erfurth U. Bolz M, et al. Among authors: geitzenauer w. Br J Ophthalmol. 2007 Jun;91(6):785-9. doi: 10.1136/bjo.2006.102467. Epub 2006 Oct 18. Br J Ophthalmol. 2007. PMID: 17050580 Free PMC article. Clinical Trial.

7

[Early effects of systemic and intravitreal bevacizumab (avastin) therapy for neovascular age-related macular degeneration].

Geitzenauer W, Michels S, Prager F, Kornek G, Vormittag L, Rosenfeld P, Schmidt-Erfurth U. Geitzenauer W, et al. Klin Monbl Augenheilkd. 2006 Oct;223(10):822-7. doi: 10.1055/s-2006-926875. Klin Monbl Augenheilkd. 2006. PMID: 17063425 Clinical Trial. German.

8

Human macula investigated in vivo with polarization-sensitive optical coherence tomography.

Pircher M, Götzinger E, Findl O, Michels S, Geitzenauer W, Leydolt C, Schmidt-Erfurth U, Hitzenberger CK. Pircher M, et al. Among authors: geitzenauer w. Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5487-94. doi: 10.1167/iovs.05-1589. Invest Ophthalmol Vis Sci. 2006. PMID: 17122140

9

Retinal pigment epithelium tears following intravitreal ranibizumab therapy.

Kiss C, Michels S, Prager F, Geitzenauer W, Schmidt-Erfurth U. Kiss C, et al. Among authors: geitzenauer w. Acta Ophthalmol Scand. 2007 Dec;85(8):902-3. doi: 10.1111/j.1600-0420.2007.00928.x. Epub 2007 Apr 4. Acta Ophthalmol Scand. 2007. PMID: 17408387 Free article.

10

Choroidal neovascularization secondary to Sorsby fundus dystrophy treated with systemic bevacizumab (Avastin).

Prager F, Michels S, Geitzenauer W, Schmidt-Erfurth U. Prager F, et al. Among authors: geitzenauer w. Acta Ophthalmol Scand. 2007 Dec;85(8):904-6. doi: 10.1111/j.1600-0420.2007.00927.x. Epub 2007 Apr 13. Acta Ophthalmol Scand. 2007. PMID: 17433023 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters